BRK-B vs IGR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Despite a strong Piotroski F-Score of 7/9 indicating operational health, IGR exhibits severe valuation and sustainability concerns. The stock trades at a significant premium to both its Graham Number ($3.48) and Intrinsic Value ($0.84), while revenue is contracting by 15.30% YoY. Most critically, the 600% dividend payout ratio indicates that the 15.35% yield is fundamentally unsustainable and likely funded by capital returns rather than earnings. The combination of negative growth and a disconnected valuation outweighs the strong deterministic health score.
Compare Another Pair
Related Comparisons
BRK-B vs IGR: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and CBRE Global Real Estate Income Fund (IGR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.